Estimate delivery
Actual EPS versus consensus
Actual and estimated EPS are displayed in reported currency on the same quarterly basis.
US Equity · NASDAQ · Earnings Dossier
TLX earnings intelligence
Telix Pharmaceuticals LimitedHealthcare · Biotechnology · USD reporting basis
Current earnings profile
Results and price are diverging
The sign of the earnings surprise has often differed from the direction of the next completed weekly close.
Evidence73/100 · Strong
Next scheduled catalyst
No forward date is currently stored
The historical dossier remains available while the next calendar date is unconfirmed.
0event risk
Inactive
Countdown-calendar proximity
EPS estimate-provider consensus
Estimate growth-versus comparable year-ago actual
Historical movement12.6%average absolute next weekly close
Three-year earnings transmission
Delivered earnings power versus market price
Three-year relationship unavailable
A full 156-week price window is needed.
Beat rate33.3%1 beats in 3 measured quarters
Average surprise-36.0%median -48.1%
Delivery streak11 consecutive misses
Average response+12.6%6 measured reactions
Result-price confirmation33%same directional sign
Surprise variability54.0 ptspopulation dispersion
Price acceptance
Surprise and next weekly close
The response uses the first completed weekly close after the public report against the prior completed weekly close.
Fundamental delivery
Quarterly revenue and net income
Reported financial statements provide scale and earnings quality context around the headline EPS result.
Transmission matrix
Does price confirm delivery?
Upper right and lower left observations confirm the sign of delivery. The other quadrants expose expectation or resilience effects.
Current business context
Growth, quality and valuation
EPS growth-year on year
Revenue growth201.3%year on year
Average surprise-36.0%latest four quarters
SUE-0.55standardised surprise
Net margin2.0%trailing basis
Cash conversion1.98xcash flow / net income
P/E99.6xcurrent snapshot
Data completeness93%alphavantage
Market context
Positioning into the event
Weekly close11.52 USDcompleted week
13-week return7.9%price momentum
Fair-value gap-7.6%price versus current fair value
Relative strength6.3exchange benchmark
Trend signalActiveweekly architecture
Next-week stateNegative31.6%
Market context describes the setup surrounding the report. It does not convert the earnings event into a directional forecast.
Reported evidence ledger
Quarter-by-quarter delivery and acceptance
Each row preserves the reported estimate, public date, statement context and conservative weekly reaction measurement.
Reported / periodEPS actual / estimateSurpriseEPS growthRevenue / growthNext close / four weeksRead
Reported / period2 Jul 202630 Jun 2026 · exact
EPS actual / estimate- / -0.01USD
Surprise-Unavailable
EPS growth-year on year
Revenue / growth-- · USD
Next close / four weeks+11.4% / -4.1%completed weekly closes
ReadUnavailableresult versus price sign
Reported / perioddate unavailable31 Mar 2026 · period only
EPS actual / estimate- / -0.01USD
Surprise-Unavailable
EPS growth-year on year
Revenue / growth-- · USD
Next close / four weeks- / -completed weekly closes
ReadUnavailableresult versus price sign
Reported / period19 Feb 202631 Dec 2025 · exact
EPS actual / estimate0.04 / 0.08USD
Surprise-48.1%Miss
EPS growth-33.3%year on year
Revenue / growth620440540+4.4% · USD
Next close / four weeks+17.6% / +20.0%completed weekly closes
ReadDivergedresult versus price sign
Reported / period14 Oct 202530 Sep 2025 · exact
EPS actual / estimate-0.09 / -0.14USD
Surprise+35.3%Beat
EPS growth-year on year
Revenue / growth-- · USD
Next close / four weeks+12.9% / +1.5%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period20 Aug 202530 Jun 2025 · exact
EPS actual / estimate0.01 / 0.21USD
Surprise-95.3%Miss
EPS growth-year on year
Revenue / growth593111464+213.9% · USD
Next close / four weeks+8.1% / -20.2%completed weekly closes
ReadDivergedresult versus price sign
Reported / period22 Apr 202531 Mar 2025 · exact
EPS actual / estimate0.09 / 0.00USD
Surprise-Unavailable
EPS growth-year on year
Revenue / growth-- · USD
Next close / four weeks+12.5% / -0.2%completed weekly closes
ReadUnavailableresult versus price sign
Reported / period20 Feb 202531 Dec 2024 · exact
EPS actual / estimate0.06 / 0.00USD
Surprise-Unavailable
EPS growth-year on year
Revenue / growth594244000+110.9% · USD
Next close / four weeks+13.4% / +0.6%completed weekly closes
ReadUnavailableresult versus price sign
Reported / period17 Oct 202430 Sep 2024 · exact
EPS actual / estimate0.00 / 0.00USD
Surprise-Unavailable
EPS growth-year on year
Revenue / growth-- · USD
Next close / four weeks- / -completed weekly closes
ReadUnavailableresult versus price sign
Reproducible method
How the earnings dossier is measured
Reported diluted EPS is compared with the stored estimate for the same fiscal period. Moves within ±0.5% are classified as in-line.
The first completed weekly close after the public date is compared with the prior completed weekly close. Four-week response uses the first close at least 21 days later.
Risk combines proximity, average absolute price movement, surprise variability, estimate availability and timing certainty. It does not score direction.
Exact public dates are used when stored. Missing estimates, timing and statement fields remain missing. No result or reaction is filled from a future observation.
Independent market research for education. Not investment advice, a recommendation, forecast, target or execution instruction.